Skip to Content

Newsroom

Best therapies for relapsed diffuse large b-cell lymphoma

Cancer Newsline - 07/28/2014

When diffuse large b-cell lymphoma returns after the cancer patient is initially treated, it is called relapsed diffuse large b-cell lymphoma (DLBCL). If this happens, other therapies besides the standard R-CHOP (chemotherapy drugs cyclophosphamide, doxorubicin, vincristine, and prednisone) may be successful in fighting the disease. Jason Westin, M.D., assistant professor in Lymphoma/Myeloma at MD Anderson Cancer Center, discusses these therapies, including high dose chemotherapy combined with stem cell transplantation, as well as clinical trials for relapsed diffuse large b-cell lymphoma.

Guest: Jason Westin, M.D.

Request an Appointment

Subscribe to Cancer Newsline


Subscribe to Cancer 
Newsline on iTunesU

What is iTunesU?iTunesU is a part of the iTunes Store that features free podcasts, lectures and other educational content that you can download to your Mac or PC, iPhone, iPod, or other portable device. 

Sign up to receive Cancer Newsline in your RSS Feed.

 



© 2014 The University of Texas MD Anderson Cancer Center